Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)

• Glavni autori: Park JS (Autor), Shin JH (Autor), Hong TJ (Autor), Seo HS (Autor), Shim WJ (Autor), Baek SH (Autor), Jeong JO (Autor), Ahn YK (Autor), Kang WC (Autor), Kim YH (Autor), Kim SH (Autor), Hyon MS (Autor), Choi DH (Autor), Nam CW (Autor), Park TH (Autor), Lee SC (Autor), Kim HS (Autor)
• Format: Knjiga
• Izdano: Dove Medical Press, 2016-08-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Jin-Sun Park,1,* Joon-Han Shin,1,* Taek-Jong Hong,2 Hong-Seog Seo,3 Wan-Joo Shim,4 Sang-Hong Baek,5 Jin-Ok Jeong,6 Youngkeun Ahn,7 Woong-Chol Kang,8 Young-Hak Kim,9 Sang-Hyun Kim,10 Min-Su Hyon,11 Dong-Hoon Choi,12 Chang-Wook Nam,13 Tae-Ho Park,14 Sang-Chol Lee,15 Hyo-Soo Kim16 1Department of Cardio...